Clinical Trial Update: Superoxide Dismutase (SOD) as Antioxidant Treatment OF Age Related Macular Degeneration (ARMD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Superoxide Dismutase as an antioxidant treatment for age-related macular degeneration has completed. Sponsor: Centre de Recher…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Superoxide Dismutase (superoxide dismutase)

Snippet

Sponsor: Centre de Recherche en Nutrition Humaine Rhone-Alpe | Conditions: Age Related Macular Degeneration | Phase 3 | Status: COMPLETED